CMN LIFU for Enhanced Glymphatic Clearance in Amyloid-Positive MCI
CMN LIFU for Enhanced Glymphatic Clearance in Amyloid-Positive MCI
Not yet recruiting · NCT07866768 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CMN LIFU for Enhanced Glymphatic Clearance in Amyloid-Positive MCI | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Not applicable | 2026-10-08 | NCT07866768 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Attune Neurosciences Inc | 6 |
| Gates Ventures | 1 |
| University of California, San Francisco | 637 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of California San Francisco | San Francisco | United States | 6 |